The Discounted Cash Flow (DCF) valuation of RegeneRx Biopharmaceuticals Inc (RGRX) is (35.23) USD. With the latest stock price at 0.00 USD, the upside of RegeneRx Biopharmaceuticals Inc based on DCF is -17616266.7%.
Based on the latest price of 0.00 USD and our DCF valuation, RegeneRx Biopharmaceuticals Inc (RGRX) is a sell. selling RGRX stocks now will result in a potential gain of 17616266.7%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.6% - 6.2% | 5.4% |
| Long-term Growth Rate | 3.0% - 4.4% | 3.7% |
| Fair Price | (229.30) - (19.96) | (35.23) |
| Upside | -114652453.2% - -9977832.2% | -17616266.7% |